FINERENONE AND APPARENT TREATMENT-RESISTANT HYPERTENSION IN HEART FAILURE WITH MILDLY REDUCED OR PRESERVED EJECTION FRACTION

Brigham and Women’s Hospital and Harvard Medical School; British Heart Foundation Cardiovascular Research Centre, University of Glasgow; National Heart Centre Singapore and Duke-National University of Singapore; University of Milano-Bicocca ASST Papa

The study explores the relationship between finerenone treatment and various cardiovascular outcomes in patients suffering from heart failure. It emphasizes the challenges of managing hypertension in this population and evaluates the efficacy of finerenone as a therapeutic option. The findings are based on a comprehensive analysis of clinical data, aiming to provide insights into treatment-resistant hypertension and its implications for heart failure management.